- Home
- / Caplin Point Laboratories
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Caplin Point Laboratories financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₹1.9 K
2024-10-29
Market Capitalization
₹145.8 B
2024-10-29
Revenue
₹16.8 B
FY, 2024
CreditSafe Score
?
Score changed on Jan 21, 2025
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| INR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 5.3B | 6.5B | 8.4B | 10.5B | 12.6B | 14.5B | 16.8B |
| Cost of goods sold | 2.4B | 2.9B | 4.1B | 4.7B | 5.6B | 6.6B | 7.2B |
| Gross profit | 3.0B | 3.6B | 4.5B | 5.9B | 7.1B | 8.1B | 9.8B |
| Gross profit margin, % | 57.4% | 55.8% | 53.4% | 56.5% | 56.6% | 55.6% | 58.2% |
| Operating expense total | 1.1B | 1.3B | 1.9B | 2.6B | 3.2B | 3.6B | 4.2B |
| Depreciation and amortization | 190.0M | 234.3M | 316.2M | 369.7M | 469.0M | 449.9M | 534.4M |
| EBITDA | 2.0B | 2.3B | 2.6B | 3.3B | 4.0B | 4.5B | 5.6B |
| EBITDA margin, % | 37.2% | 36.1% | 31.0% | 31.6% | 31.5% | 30.7% | 33.3% |
| EBIT | 1.8B | 2.1B | 2.3B | 2.9B | 3.5B | 4.0B | 5.0B |
| EBIT margin, % | 33.6% | 32.5% | 27.3% | 28.1% | 27.8% | 27.6% | 30.1% |
| Interest income | 30.4M | 19.9M | 74.5M | 186.1M | 235.0M | 354.1M | 472.8M |
| Interest expense | 6.1M | 5.8M | 11.8M | 15.9M | 7.0M | 7.8M | 7.8M |
| Pre tax profit | 1.9B | 2.3B | 2.7B | 3.1B | 3.9B | 4.5B | 5.6B |
| Income tax expense | 437.4M | 503.2M | 543.8M | 621.9M | 773.7M | 743.6M | 1.0B |
| Net Income | 1.4B | 1.8B | 2.2B | 2.5B | 3.1B | 3.8B | 4.6B |